MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Intranasal delivery of insulin for the restoration of memory signaling in Alzheimer disease

    M. Bhargava, S. Bhargava, V. Bhargava (Kanpur, India)

    Objective: Objective of this study is to develop delivery-system to overcome BBB by employing novel, non-invasive approach via nasal route. The olfactory neural pathway provides…
  • 2017 International Congress

    Multidisciplinary Parkinson rehabilitation delays nursing home admission and is cost-effective.

    E. Steendam-Oldekamp, W. Rutgers, T. van Laar (Groningen, Netherlands)

    Objective: The purpose of this program was to analyze whether activities of daily living (ADL) could be improved, thereby delaying definite nursing home admission and…
  • 2017 International Congress

    AAV-mediated over-expression of VEGF-B in PINK1 gene knockout rats increases striatal dopamine content

    T. Falk, M. Bartlett, D. Muller, B. Silashki, D. Farrell, K. Parent, M. Heien, S. Sherman (Tucson, AZ, USA)

    Objective: To evaluate overexpression of the neuroprotective vascular endothelial growth factor B (VEGF-B) in a genetic Parkinson’s disease (PD) model. Background: We have shown in…
  • 2017 International Congress

    Exercise preferences of people with Parkinson’s disease: preliminary findings of a discrete choice experiment

    C. Canning, C. Canning, S. Paul, J. Bampton, C. Sherrington, K. Howard (Lidcombe, Sydney, Australia)

    Objective: To identify which exercise program attributes most commonly drive willingness of people with Parkinson’s disease (PD) to participate in evidence-based exercise programs. Background: A…
  • 2017 International Congress

    Impact of weekly dance classes on quality of life of individuals with Parkinson’s Disease.

    L. Krejcova, J. Brito, W. Cohen, C. Bahia (Belem, Brazil)

    Objective: The aim of the present study is to investigate the short-term effects of weekly dance classes on the Quality of Life (QOL) of PD…
  • 2017 International Congress

    A model community neurofitness and wellness center for people with Parkinson disease. 1-year group pilot data

    E. Borchers, B. Farley, D. Snider, T. McIsaac, J. Bazan-Wigle (Tucson, AZ, USA)

    Objective: Report preliminary one-year benefits of ongoing research-based community group exercise programs integrated with 6-month therapy coaching for people of varying disease severity (to date,…
  • 2017 International Congress

    Clinical Experience with Initiation of Carbidopa/Levodopa Enteral Suspension in Parkinson’s Disease Patients with Cognitive Impairment

    P. Dowell, K. Lyons, R. Pahwa (Kansas City, KS, USA)

    Objective: To assess the safety and efficacy of carbidopa/levodopa enteral suspension (CLES) in Parkinson’s disease (PD) patients with cognitive impairment. Background: As Parkinson’s Disease progresses,…
  • 2017 International Congress

    Three-year follow-up of high-dose ubiquinol supplementation in a case of familial multiple system atrophy with compound heterozygous COQ2 mutations

    J. Mitsui, K. Koguchi, T. Momose, M. Takahashi, T. Matsukawa, T. Yasuda, S.-i. Tokushige, H. Ishiura, J. Goto, S. Nakazaki, T. Kondo, H. Ito, Y. Yamamoto, S. Tsuji (Tokyo, Japan)

    Objective: To present the detailed clinical features of a patient with familial MSA carrying compound heterozygous COQ2 mutations and report the outcome of a high-dose ubiquinol…
  • 2017 International Congress

    How Usual Is Skin Rashes During Treatment With Levodopa / Benserazide Hydrochloride?

    E. Okuyucu, M. Uzel, S. Colakoglu Yesıldag, M. Guntel (Hatay, Turkey)

    Objective: To clarify the possible associations of  levodopa / benserazidehydrochloride usage and  skin rashes. Background:   Levodopa/benserazide hydrochloride   is one of the best dopaminergic drug used…
  • 2017 International Congress

    Parkinson Syndrome associated with inositol-1,4,5-triphosphate receptor antigen type 1 (ITPR1) antibodies

    B. Wimmer, K. Fuchs, U. Bogdahn, A. Heimeroth (Regensburg, Germany)

    Objective: To illustrate an unusual clinical presentation of Parkinson´s disease (PD) that was effectively treated with immune adsorption. Background: Autoimmune mediated movement disorders may be…
  • « Previous Page
  • 1
  • …
  • 1264
  • 1265
  • 1266
  • 1267
  • 1268
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley